Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hein

Showing results (331-340 of 477) with videos related to

Pageof 48
Sort By:
Journal of Oncology|September 19, 2019
<i>N</i>-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell LinesMarcus W Stepp, Raúl A Salazar-González, Kyung U Hong, et al.
Cancer Detection and Prevention|June 29, 2002
Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predispositionAdrian J Fretland, Mark A Doll, Yuanqi Zhu, et al.
Toxicology and Applied Pharmacology|April 11, 2006
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblastsPayal Bhaiya, Sanjoy Roychowdhury, Piyush M Vyas, et al.
Pharmacogenetics and Genomics|June 4, 2014
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Ellen M McDonagh, Sotiria Boukouvala, Eleni Aklillu, et al.
Toxicology and Applied Pharmacology|January 1, 1994
Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogensD W Hein, M A Doll, T D Rustan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2007
Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elementsAnwar Husain, Xiaoyan Zhang, Mark A Doll, et al.
Journal of Molecular and Cellular Cardiology|April 25, 2019
Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arteriolesTravis W Hein, Xin Xu, Yi Ren, et al.
Toxicology and Applied Pharmacology|March 30, 2022
Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cellsJames T F Wise, Raúl A Salazar-González, Mariam R Habil, et al.
Mutation Research|October 24, 2007
Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxibSrivani Ravoori, Yi Feng, Jason R Neale, et al.
Journal of the American College of Cardiology|August 16, 2008
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heartGuihua Zhou, Xiaokun Li, David W Hein, et al.
Pageof 48

Showing results (331-340 of 477) with videos related to

Sort By:
Pageof 48
Journal of Oncology|September 19, 2019
<i>N</i>-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell LinesMarcus W Stepp, Raúl A Salazar-González, Kyung U Hong, et al.
Cancer Detection and Prevention|June 29, 2002
Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predispositionAdrian J Fretland, Mark A Doll, Yuanqi Zhu, et al.
Toxicology and Applied Pharmacology|April 11, 2006
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblastsPayal Bhaiya, Sanjoy Roychowdhury, Piyush M Vyas, et al.
Pharmacogenetics and Genomics|June 4, 2014
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Ellen M McDonagh, Sotiria Boukouvala, Eleni Aklillu, et al.
Toxicology and Applied Pharmacology|January 1, 1994
Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogensD W Hein, M A Doll, T D Rustan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2007
Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elementsAnwar Husain, Xiaoyan Zhang, Mark A Doll, et al.
Journal of Molecular and Cellular Cardiology|April 25, 2019
Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arteriolesTravis W Hein, Xin Xu, Yi Ren, et al.
Toxicology and Applied Pharmacology|March 30, 2022
Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cellsJames T F Wise, Raúl A Salazar-González, Mariam R Habil, et al.
Mutation Research|October 24, 2007
Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxibSrivani Ravoori, Yi Feng, Jason R Neale, et al.
Journal of the American College of Cardiology|August 16, 2008
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heartGuihua Zhou, Xiaokun Li, David W Hein, et al.
Pageof 48